KYNVITAR Trademark

Trademark Overview


On Wednesday, February 3, 2016, a trademark application was filed for KYNVITAR with the United States Patent and Trademark Office. The USPTO has given the KYNVITAR trademark a serial number of 79186274. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, March 17, 2023. This trademark is owned by NOVARTIS AG. The KYNVITAR trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; anti-fungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the preven...
kynvitar

General Information


Serial Number79186274
Word MarkKYNVITAR
Filing DateWednesday, February 3, 2016
Status709 - CANCELLED - SECTION 71
Status DateFriday, March 17, 2023
Registration Number5033985
Registration DateTuesday, September 6, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 21, 2016

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; anti-fungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma; biological preparations and stem cells for pharmaceutical and medical use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, March 17, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH

Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH

Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events


Event DateEvent Description
Monday, December 25, 2023TOTAL INVALIDATION PROCESSED BY THE IB
Friday, December 1, 2023TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Friday, December 1, 2023INVALIDATION PROCESSED
Friday, November 17, 2023TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, March 17, 2023CANCELLED SECTION 71
Friday, June 9, 2017NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Friday, November 11, 2016NOTIFICATION PROCESSED BY IB
Tuesday, October 25, 2016FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, October 25, 2016FINAL DISPOSITION PROCESSED
Thursday, October 6, 2016GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, September 6, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, June 21, 2016PUBLISHED FOR OPPOSITION
Wednesday, June 1, 2016NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, June 1, 2016NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, June 1, 2016NOTICE OF PUBLICATION
Thursday, May 12, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, May 9, 2016ASSIGNED TO EXAMINER
Tuesday, May 3, 2016APPLICATION FILING RECEIPT MAILED
Friday, April 29, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 28, 2016LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, April 28, 2016SN ASSIGNED FOR SECT 66A APPL FROM IB